Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.455 USD | +1.36% |
|
-0.44% | -35.66% |
05-10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
552M | - | - | - | - | - | |
122B | ||||||
116B | ||||||
27.03B | - | |||||
20.36B | - | |||||
16.43B |